Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Connective tissue disease: an approach

E F Morand1

  • 1Monash Medical Centre, Clayton, Victoria.

Australian Family Physician
|December 1, 1993
PubMed
Summary

Connective tissue diseases involve immune system abnormalities. This article offers a classification system to aid in evaluating and understanding these complex conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.

Lupus·2018
Same author

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus.

Scientific reports·2018
Same author

Discordance of patient and physician health status concerns in systemic lupus erythematosus.

Lupus·2017
Same author

Validation of the Lupus Impact Tracker in an Australian patient cohort.

Lupus·2016
Same author

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus.

Scientific reports·2016
Same author

Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort.

Lupus science & medicine·2015

Area of Science:

  • Immunology
  • Rheumatology
  • Pathology

Background:

  • Connective tissue diseases (CTDs) represent a spectrum of disorders.
  • These conditions are characterized by aberrant immune system activity.
  • The precise definition and classification of CTDs remain challenging.

Purpose of the Study:

  • To establish a systematic approach for the evaluation of connective tissue diseases.
  • To provide a framework for the classification of these complex conditions.
  • To enhance reader confidence in managing and understanding CTDs.

Main Methods:

  • Review of existing literature on connective tissue diseases.
  • Development of a novel classification system based on key pathological and immunological features.
  • Synthesis of diagnostic criteria for improved categorization.

Main Results:

  • A proposed system for the overall evaluation of CTDs.
  • A structured classification enabling differentiation between various CTDs.
  • Guidelines for approaching these multifaceted conditions.

Conclusions:

  • The proposed system facilitates a more confident approach to diagnosing and classifying CTDs.
  • Improved classification aids in understanding the underlying immune system dysregulation.
  • This framework supports further research and clinical management of connective tissue diseases.

Related Experiment Videos